Marosi Christine, Preusser Matthias
Division of Oncology, Department of Medicine I, Medical University Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Memo. 2017;10(1):18-21. doi: 10.1007/s12254-016-0309-x. Epub 2017 Jan 25.
For neuro-oncologists, much was accomplished in the last decade, including the establishment of the first standard of care (SOC) in this field of oncology. New treatment options boosted research in the whole field of neuro-oncology, as well clinical trials, translational and basic research. Accumulated data on molecular-genetic subgroups with distinct clinical outcomes in disease entities led to the establishment of new biomarkers and to the collaborative formulation of a new WHO classification of central nervous system tumors.
对于神经肿瘤学家而言，过去十年取得了诸多成就，包括在该肿瘤学领域确立了首个标准治疗方案（SOC）。新的治疗选择推动了神经肿瘤学整个领域的研究，以及临床试验、转化研究和基础研究。关于疾病实体中具有不同临床结果的分子遗传亚组的累积数据，促成了新生物标志物的建立以及世界卫生组织（WHO）中枢神经系统肿瘤新分类的协同制定。
